202 related articles for article (PubMed ID: 18442282)
21. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
22. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
Herringson TP; Altin JG
J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
[TBL] [Abstract][Full Text] [Related]
23. Profiling RNA interference (RNAi)-mediated toxicity in neural cultures for effective short interfering RNA design.
Read ML; Mir S; Spice R; Seabright RJ; Suggate EL; Ahmed Z; Berry M; Logan A
J Gene Med; 2009 Jun; 11(6):523-34. PubMed ID: 19322910
[TBL] [Abstract][Full Text] [Related]
24. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.
de Jonge J; Holtrop M; Wilschut J; Huckriede A
Gene Ther; 2006 Mar; 13(5):400-11. PubMed ID: 16267567
[TBL] [Abstract][Full Text] [Related]
25. Macrolide- and tetracycline-adjustable siRNA-mediated gene silencing in mammalian cells using polymerase II-dependent promoter derivatives.
Malphettes L; Fussenegger M
Biotechnol Bioeng; 2004 Nov; 88(4):417-25. PubMed ID: 15382105
[TBL] [Abstract][Full Text] [Related]
26. siRNA binding proteins of microglial cells: PKR is an unanticipated ligand.
Zhang Z; Weinschenk T; Guo K; Schluesener HJ
J Cell Biochem; 2006 Apr; 97(6):1217-29. PubMed ID: 16315288
[TBL] [Abstract][Full Text] [Related]
27. Studies of a viral suppressor of RNA silencing p19-CFP fusion protein: a FRET-based probe for sensing double-stranded fluorophore tagged small RNAs.
Koukiekolo R; Jakubek ZJ; Cheng J; Sagan SM; Pezacki JP
Biophys Chem; 2009 Aug; 143(3):166-9. PubMed ID: 19491057
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric RNA duplexes mediate RNA interference in mammalian cells.
Sun X; Rogoff HA; Li CJ
Nat Biotechnol; 2008 Dec; 26(12):1379-82. PubMed ID: 19029911
[TBL] [Abstract][Full Text] [Related]
29. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
[TBL] [Abstract][Full Text] [Related]
30. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing.
Chung HJ; Hong CA; Lee SH; Jo SD; Park TG
Bioconjug Chem; 2011 Feb; 22(2):299-306. PubMed ID: 21222435
[TBL] [Abstract][Full Text] [Related]
31. Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures.
Tanaka M; Yanagawa Y; Hirashima N
J Neurosci Methods; 2009 Mar; 178(1):80-6. PubMed ID: 19114056
[TBL] [Abstract][Full Text] [Related]
32. PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.
Liu XX; Rocchi P; Qu FQ; Zheng SQ; Liang ZC; Gleave M; Iovanna J; Peng L
ChemMedChem; 2009 Aug; 4(8):1302-10. PubMed ID: 19533723
[TBL] [Abstract][Full Text] [Related]
33. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
Kim J; Lee SH; Choe J; Park TG
J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
[TBL] [Abstract][Full Text] [Related]
34. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.
Bartz R; Fan H; Zhang J; Innocent N; Cherrin C; Beck SC; Pei Y; Momose A; Jadhav V; Tellers DM; Meng F; Crocker LS; Sepp-Lorenzino L; Barnett SF
Biochem J; 2011 Apr; 435(2):475-87. PubMed ID: 21265735
[TBL] [Abstract][Full Text] [Related]
35. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
[TBL] [Abstract][Full Text] [Related]
36. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
[TBL] [Abstract][Full Text] [Related]
37. Peptide-based strategy for siRNA delivery into mammalian cells.
Simeoni F; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2005; 309():251-60. PubMed ID: 15990405
[No Abstract] [Full Text] [Related]
38. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
Bioconjug Chem; 2008 Nov; 19(11):2156-62. PubMed ID: 18850733
[TBL] [Abstract][Full Text] [Related]
39. RNAi therapeutics: an update on delivery.
Nguyen T; Menocal EM; Harborth J; Fruehauf JH
Curr Opin Mol Ther; 2008 Apr; 10(2):158-67. PubMed ID: 18386228
[TBL] [Abstract][Full Text] [Related]
40. Physicochemical characterization of siRNA-peptide complexes.
Law M; Jafari M; Chen P
Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
